Bath system for chronic skin conditions
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a special bath system (Thera-Clean Microbubbles) to see if it helps people with certain skin conditions like psoriasis, eczema, epidermolysis bullosa, or ichthyosis. It's designed for people whose skin is stable and who can follow a home bathing routine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 years old or older.
- You have psoriasis, atopic dermatitis (eczema), epidermolysis bullosa, or ichthyosis.
- Your skin condition has been stable (not getting worse) for at least 4 weeks.
- You are willing to follow the study's bathing instructions at home.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
This study tests whether cleaning the skin to remove a common bacteria (Staph aureus) can help reduce eczema symptoms. It may offer a new way to manage eczema without relying only on creams or injections.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This study tests a tiny device that samples your skin to help doctors understand psoriasis and eczema better. It may help guide more personalized treatment for your condition.
This trial tests an experimental drug called BBT001 for people with moderate to severe eczema (atopic dermatitis) that hasn't been helped enough by creams. The study is in early phases, so it will check how safe the drug is and how well it might work.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
Hear when a new Ichthyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.